RT-RPA as a dual tool for detection and phylogenetic analysis of epidemic arthritogenic alphaviruses

Sainetra Sridhar1,2, Prince Baffour Tonto1,2, Lily Lumkong1,2

  • 1Rutgers Global Health Institute, Rutgers University, New Brunswick, NJ, USA.

Scientific Reports
|December 3, 2024
PubMed

Insights

New rapid diagnostic tests for Chikungunya (CHIKV), o'nyong-nyong (ONNV), and Mayaro (MAYV) viruses offer sensitive and specific detection. These point-of-care tests are crucial for early diagnosis of these mosquito-borne alphaviruses.

Area of Science:

  • Medical Entomology
  • Virology
  • Molecular Diagnostics

Background:

  • Chikungunya (CHIKV), o'nyong-nyong (ONNV), and Mayaro (MAYV) are mosquito-borne alphaviruses causing arthritogenic syndromes.
  • Outbreaks occur in tropical/subtropical regions, highlighting a need for better diagnostics.
  • Current tests (ELISA, qPCR) have limitations like cross-reactivity or requiring specialized labs.

Purpose of the Study:

  • To develop and validate rapid, virus-specific point-of-care diagnostic tests for CHIKV, ONNV, and MAYV.
  • To address the critical gap in sensitive and specific diagnostics for these arboviruses.

Main Methods:

  • Development of three virus-specific reverse transcription recombinase polymerase amplification (RT-RPA) assays.
  • Validation using viral copies and clinical samples (mouse and human).
  • Assessment of amplicon sequencing for molecular epidemiology.

Main Results:

  • RT-RPA tests detected 10-100 viral copies within 20 minutes.
  • Tests demonstrated high sensitivity and specificity, with no cross-reactivity.
  • Successful application in detecting CHIKV, ONNV, and MAYV in clinical samples.

Conclusions:

  • Developed RT-RPA assays are rapid, sensitive, and specific for CHIKV, ONNV, and MAYV detection.
  • These diagnostics are suitable for early detection, especially in resource-limited settings.
  • Enables cost-effective molecular epidemiology through amplicon sequencing.